Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance [Phase 2]
A Phase 2 trial evaluated a pomegranate-extract pill for preventing tumor growth in localized prostate cancer patients on active surveillanc…
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA [Phase 2]
Phase 2 clinical trial evaluating the effect of modified citrus pectin on PSA kinetics in biochemically recurrent prostate cancer after PSA …
-
CLINICAL_TRIALS trial_result · 2020-01-28Clinical Trial Update: Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium [Phase 3]
Phase 3 trial update exploring minocycline to attenuate postoperative cognitive dysfunction and delirium.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy [Phase 2]
Phase 2 clinical trial evaluating feasibility and toxicity of degarelix for downsizing before permanent seed prostate brachytherapy in prost…
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer [Phase 1, Phase 2]
Phase 1/2 trial update for an experimental in-situ cancer vaccine across multiple solid tumors, including breast, colorectal, prostate, mela…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI [Phase 1, Phase 2]
Clinical trial evaluating pretreatment staging of high-risk prostate cancer using 18F-Fluciclovine PET/MRI across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) [Phase 3]
Phase 3 ENZAMET trial comparing enzalutamide plus androgen deprivation therapy versus placebo plus ADT in metastatic hormone-sensitive prost…
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer [Phase 3]
Phase 3 trial update for abiraterone acetate plus prednisone in chemo-naive metastatic castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Quell Opioid Reduction and Pain Relief in Patients With Cancer [NA]
A terminated clinical trial update for Quell opioid reduction and pain relief in cancer patients, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy [Phase 2]
Phase II neoadjuvant study in localized prostate cancer investigating apalutamide, abiraterone acetate, prednisone, degarelix, and indometha…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer [Phase 3]
Phase 3 trial evaluating surgery with or without docetaxel and leuprolide or goserelin for high-risk localized prostate cancer; status ACTIV…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy [Phase 2]
Phase 2 study of abiraterone acetate in chemo-naive metastatic castration-resistant prostate cancer patients with prior diethylstilbestrol e…
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer [Phase 1, Phase 2]
Clinical trial update on radiation therapy for stage II/III prostate cancer (Phase 1/2) completed.
-
FDA approval · 2019-12-27FDA Approved: LYNPARZA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for LYNPARZA (olaparib) from AstraZeneca Pharmaceuticals LP. The approval updates the product labeli…
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Impact of Catheter Size on Peri-Operative Pain After Robotic Assisted Laparoscopic Prostatectomy [NA]
Clinical trial update assessing how catheter size affects peri-operative pain after robotic-assisted laparoscopic prostatectomy.
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer [Phase 1]
Phase 1 trial of a multi-target recombinant vaccine targeting CEA/MUC1/Brachyury in advanced cancer completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: Prostate Cancer Survivors and Exercise and Behavioral Counseling [Phase 2]
A Phase 2 clinical trial update evaluating exercise and behavioral counseling for prostate cancer survivors, completed, with outcomes likely…
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 study update evaluating safety and pharmacokinetics of ODM-204 in metastatic castration-resistant prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: FACBC Prostate Therapy Response [Phase 2]
Phase 2 clinical trial update for FACBC prostate therapy in prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer [Phase 3]
Expanded access trial update for diagnostic imaging in staging recurrent metastatic prostate cancer; Phase 3 completed with results posted.
-
FDA approval · 2019-12-16FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for XTANDI (enzalutamide) from Astellas Pharma US, resulting in an updated label.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Doxercalciferol Before Surgery in Treating Localized Prostate Cancer [Phase 2]
This is a Phase 2 clinical trial update evaluating doxercalciferol before surgery in localized prostate cancer.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
Phase 2 clinical trial update for perillyl alcohol in metastatic prostate cancer after hormone therapy failure. Status: COMPLETED.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Effect of Cancer Nurse Navigators on Patient Outcomes [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating the impact of cancer nurse navigators on patient outcomes has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide [Phase 2]
A Phase 2 trial evaluating abiraterone acetate plus LHRH agonist, and abiraterone acetate plus LHRH agonist with enzalutamide, in prostate c…